BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 9020774)

  • 1. Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.
    Wang Y; Hamasaki K; Rando RR
    Biochemistry; 1997 Jan; 36(4):768-79. PubMed ID: 9020774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity in the binding of aminoglycosides to HIV-RRE RNA.
    Cho J; Rando RR
    Biochemistry; 1999 Jun; 38(26):8548-54. PubMed ID: 10387102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence-based approach for detecting and characterizing antibiotic-induced conformational changes in ribosomal RNA: comparing aminoglycoside binding to prokaryotic and eukaryotic ribosomal RNA sequences.
    Kaul M; Barbieri CM; Pilch DS
    J Am Chem Soc; 2004 Mar; 126(11):3447-53. PubMed ID: 15025471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
    Nam YS; Petrovic A; Jeong KS; Venkatesan S
    J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
    Daly TJ; Doten RC; Rusche JR; Auer M
    J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding kinetics and bioassay of RRE mRNA fragments to a peptide containing the recognition domain of HIV-1 Rev.
    West ML; Ramsdale TE
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):85-8. PubMed ID: 9575345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy.
    Lapidot A; Vijayabaskar V; Litovchick A; Yu J; James TL
    FEBS Lett; 2004 Nov; 577(3):415-21. PubMed ID: 15556620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal RNA constructs that specifically bind aminoglycoside antibiotics with high affinities.
    Hamasaki K; Killian J; Cho J; Rando RR
    Biochemistry; 1998 Jan; 37(2):656-63. PubMed ID: 9425088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide.
    Peterson RD; Feigon J
    J Mol Biol; 1996 Dec; 264(5):863-77. PubMed ID: 9000617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural origins of aminoglycoside specificity for prokaryotic ribosomes.
    Lynch SR; Puglisi JD
    J Mol Biol; 2001 Mar; 306(5):1037-58. PubMed ID: 11237617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance.
    Hendrix M; Priestley ES; Joyce GF; Wong CH
    J Am Chem Soc; 1997 Apr; 119(16):3641-8. PubMed ID: 11540136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
    Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
    Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding of aminoglycosides to a human rRNA construct based on a DNA polymorphism which causes aminoglycoside-induced deafness.
    Hamasaki K; Rando RR
    Biochemistry; 1997 Oct; 36(40):12323-8. PubMed ID: 9315872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of HIV Rev peptides with the Rev response element RNA.
    Williamson JR; Battiste JL; Mao H; Frankel AD
    Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational constraint as a means for understanding RNA-aminoglycoside specificity.
    Blount KF; Zhao F; Hermann T; Tor Y
    J Am Chem Soc; 2005 Jul; 127(27):9818-29. PubMed ID: 15998086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA molecules that specifically and stoichiometrically bind aminoglycoside antibiotics with high affinities.
    Wang Y; Killian J; Hamasaki K; Rando RR
    Biochemistry; 1996 Sep; 35(38):12338-46. PubMed ID: 8823168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
    Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
    Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.